Home » Medical Devices » Australia Peripheral Vascular Devices Market

Australia Peripheral Vascular Devices Market By Type (Angioplasty Balloons, Angioplasty Stents, Catheters, Guidewires, Others); By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Price: $2699

Published: | Report ID: 70215 | Report Format : PDF
REPORT ATTRIBUTE DETAILS
Historical Period  2019-2022
Base Year  2023
Forecast Period  2024-2032
Australia Peripheral Vascular Devices Market Size 2023  USD 75.14 Million
Australia Peripheral Vascular Devices Market, CAGR  6.89%
Australia Peripheral Vascular Devices Market Size 2032  USD 128.02 Million

Market Overview

The Australia Peripheral Vascular Devices Market is projected to grow from USD 75.14 million in 2023 to USD 128.02 million by 2032, at a compound annual growth rate (CAGR) of 6.89%.

The Australia Peripheral Vascular Devices market is driven by the increasing prevalence of peripheral artery diseases (PAD) and the growing aging population, which is more susceptible to vascular conditions. Technological advancements in vascular device innovation, including minimally invasive procedures and enhanced imaging technologies, are also propelling market growth. Additionally, the rising demand for effective treatments and better healthcare infrastructure contributes to the expansion of this market. The increasing awareness of peripheral vascular diseases and the availability of advanced diagnostic tools further support the adoption of peripheral vascular devices. The shift towards outpatient procedures and improvements in reimbursement policies also stimulate the demand for these devices. Trends like the development of bioresorbable vascular devices, advanced stent technologies, and the rise of non-invasive treatment options are expected to shape the market’s future. This growth is further supported by government initiatives to improve healthcare accessibility and vascular disease management in the country.

The geographical analysis of the Australia Peripheral Vascular Devices market highlights the key role of regions such as New South Wales, Victoria, and Queensland, where healthcare infrastructure and demand for advanced treatments are concentrated. These regions have seen increased adoption of peripheral vascular devices due to the rising prevalence of peripheral artery diseases (PAD) and a growing aging population. Key players in the market, including Terumo Corporation, Medtronic plc, Boston Scientific Corporation, and Abbott Laboratories, are actively involved in providing innovative vascular devices that cater to the needs of hospitals, ambulatory surgical centers, and specialty clinics. These companies are capitalizing on advancements in device technology, such as minimally invasive solutions and bioresorbable devices, to enhance patient outcomes. As the Australian healthcare sector continues to evolve, the presence of these key players is instrumental in driving the growth and adoption of peripheral vascular devices across the country.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Market Insights

  • The Australian Peripheral Vascular Devices market was valued at USD 75.14 million in 2023 and is projected to reach USD 128.02 million by 2032, growing at a CAGR of 6.89%.
  • Increasing prevalence of peripheral artery diseases (PAD) is driving demand for advanced vascular treatments.
  • Technological advancements in minimally invasive procedures and bioresorbable devices are boosting market growth.
  • The growing aging population in Australia is contributing to the rising need for specialized vascular care.
  • Key players such as Terumo Corporation, Medtronic, and Abbott Laboratories dominate the market with continuous innovations.
  • High treatment costs and regulatory barriers are key restraints limiting market growth.
  • Regional growth is led by New South Wales, Victoria, and Queensland, with rising adoption of advanced vascular devices in hospitals and outpatient settings.

Market Drivers

Rising Prevalence of Peripheral Artery Diseases (PAD)

The increasing prevalence of Peripheral Artery Diseases (PAD) in Australia is one of the primary drivers for the growth of the peripheral vascular devices market. PAD, which involves the narrowing of the arteries due to plaque build-up, is commonly associated with an aging population and lifestyle factors such as smoking, diabetes, and hypertension. For instance, PAD has been estimated to affect up to 10 percent of patients in primary care settings and over 20 percent in populations aged 75 and over. As the number of PAD cases continues to rise, there is an increased need for effective vascular devices that can diagnose and treat these conditions, thereby driving market demand.

Growing Aging Population

Australia’s aging population is another key driver of the peripheral vascular devices market. As individuals age, they become more susceptible to various vascular conditions, including PAD. For instance, according to the Australian Bureau of Statistics, the proportion of the population aged 65 years or older is projected to increase significantly by 2050. The increasing number of elderly individuals in the country demands more advanced treatments for vascular diseases. This demographic shift directly impacts the demand for peripheral vascular devices, as elderly patients require specialized care and management of vascular conditions to maintain their quality of life.

Technological Advancements in Peripheral Vascular Devices

Innovations in vascular device technologies have significantly contributed to the market growth. Devices such as advanced stents, catheters, and bioresorbable materials are offering improved outcomes for patients. Minimally invasive procedures and innovations in imaging technologies, such as intravascular ultrasound and angiography, have enhanced the accuracy of procedures, reducing complications and recovery times. These technological advancements are encouraging more widespread adoption of peripheral vascular devices and driving market growth in Australia.

Government Initiatives and Improved Healthcare Access

Government initiatives aimed at improving healthcare accessibility, particularly in rural areas, are helping to boost the peripheral vascular devices market. The Australian government has implemented various policies to improve the diagnosis, treatment, and management of vascular diseases. With greater focus on healthcare infrastructure, along with better reimbursement policies for vascular treatments, the demand for advanced peripheral vascular devices is on the rise. This increasing support from public health systems fosters growth within the market.

Market Trends

Shift Towards Minimally Invasive Procedures

One of the most prominent trends in the Australia peripheral vascular devices market is the growing preference for minimally invasive procedures. These procedures, which include angioplasty, stenting, and atherectomy, offer patients faster recovery times, reduced risks of complications, and shorter hospital stays. For instance, the Australian Institute of Health and Welfare reports that minimally invasive procedures, such as laparoscopic surgeries, have significantly reduced hospital stays and recovery times compared to traditional open surgeries. As a result, patients and healthcare providers are increasingly opting for these less invasive treatments, which require advanced peripheral vascular devices. This trend is reshaping the market by encouraging the development and adoption of devices designed to perform such procedures with greater precision and safety.

Development of Bioresorbable Vascular Devices

Another significant trend in the Australian market is the growing focus on bioresorbable vascular devices. These devices, which gradually dissolve in the body after performing their function, are gaining traction as they offer long-term benefits such as reducing the risk of chronic inflammation and eliminating the need for device removal procedures. Manufacturers are increasingly investing in the research and development of bioresorbable stents and scaffolds, which are expected to transform the landscape of peripheral vascular treatments, making them more patient-friendly and cost-effective.

Integration of Advanced Imaging and Diagnostic Tools

The integration of advanced imaging and diagnostic technologies with peripheral vascular devices is another trend shaping the market. Innovations such as intravascular ultrasound, optical coherence tomography, and 3D imaging are improving the accuracy of vascular disease diagnosis and treatment. These technologies help healthcare professionals visualize arterial blockages more clearly, allowing for more targeted and effective treatment with minimal risks. The incorporation of these technologies into peripheral vascular devices enhances treatment outcomes and supports the market’s growth as healthcare providers adopt them for better patient care.

Increasing Demand for Outpatient Treatments

There is also a growing trend toward outpatient treatments for peripheral vascular conditions in Australia. With the advancement of device technologies, procedures like angioplasty and stenting are now often performed on an outpatient basis, reducing healthcare costs and increasing patient convenience. This shift toward outpatient care is expected to further drive demand for peripheral vascular devices, as more individuals opt for non-hospitalized treatments. As a result, healthcare systems are increasingly integrating these advanced vascular devices into outpatient settings, improving accessibility and efficiency in managing vascular diseases.

Market Challenges Analysis

High Treatment Costs and Reimbursement Issues

One of the key challenges in the Australia peripheral vascular devices market is the high cost of treatment, which can limit accessibility for certain patient populations. Advanced peripheral vascular devices, including stents, catheters, and diagnostic imaging tools, often require significant investment from both healthcare providers and patients. Although the Australian healthcare system provides public coverage for many procedures, there are still challenges related to reimbursement for some advanced devices and treatments. For instance, the Medical Technology Association of Australia (MTAA) highlights that reimbursement processes for medical devices can be complex and vary significantly, impacting the financial viability of healthcare facilities. This can lead to financial strain for healthcare facilities, especially in rural areas, and may impact the timely adoption of newer technologies. Additionally, insurance coverage for specific treatments varies, further complicating the affordability and accessibility of these devices for patients in need.

Regulatory Hurdles and Market Competition

Another challenge facing the market is the stringent regulatory requirements for peripheral vascular devices. Regulatory approval processes can be time-consuming and costly for manufacturers, which delays the introduction of new products into the Australian market. The Australian Therapeutic Goods Administration (TGA) enforces rigorous safety and efficacy standards, and while these measures ensure patient safety, they also contribute to longer product development cycles and higher costs. Moreover, the market is highly competitive, with numerous global players striving to capture market share. Smaller companies may find it difficult to compete with well-established brands, which have significant resources to invest in research, marketing, and distribution. This intense competition, combined with regulatory barriers, makes it challenging for new players to enter the market or for existing players to differentiate themselves.

Market Opportunities

Expanding Healthcare Infrastructure and Aging Population

The growing healthcare infrastructure in Australia presents a significant market opportunity for peripheral vascular devices. As the demand for advanced treatments increases due to the rising prevalence of peripheral artery diseases (PAD), healthcare providers are investing in cutting-edge technologies. The aging population, which is more prone to vascular conditions, further amplifies this demand. Australia’s increasing focus on improving healthcare accessibility, particularly in rural and remote regions, is expected to create opportunities for the wider adoption of peripheral vascular devices. The ongoing expansion of outpatient care facilities and the integration of advanced diagnostic tools into these settings also provide manufacturers with a growing market for their devices.

Innovation and Technological Advancements

Innovation in device technology offers additional opportunities for market growth. The increasing trend toward minimally invasive procedures, such as angioplasty and stenting, is driving demand for more advanced, precise, and efficient vascular devices. There is also a rising focus on the development of bioresorbable devices, which offer long-term benefits and can help reduce the need for repeat procedures. Manufacturers that can capitalize on these trends by developing devices with improved functionality, better patient outcomes, and reduced procedural costs are poised to gain a competitive edge in the market. Furthermore, advancements in imaging technologies and AI integration for real-time diagnostics present another opportunity for growth. By aligning their products with these technological innovations, companies can expand their market presence and address the evolving needs of healthcare providers and patients in Australia.

Market Segmentation Analysis:

By Type:

The Australia Peripheral Vascular Devices market is segmented by type into angioplasty balloons, angioplasty stents, catheters, guidewires, and others. Among these, angioplasty balloons and stents dominate the market due to their widespread use in treating peripheral artery diseases (PAD) through minimally invasive procedures. Angioplasty balloons are designed to open up blocked arteries, while stents provide support to keep arteries open after treatment. Catheters and guidewires are also crucial in facilitating these procedures by allowing precise navigation and placement of balloons and stents. The “Others” segment includes diagnostic devices and bioresorbable vascular devices, which are gaining popularity for their ability to reduce long-term complications. The demand for these devices is driven by the increasing incidence of PAD, coupled with technological advancements in the development of more efficient and safer devices. As a result, the market is expected to witness continued growth in these device categories, particularly in angioplasty-related interventions.

By End-user:

The market for peripheral vascular devices in Australia is further segmented based on end-users, including hospitals, ambulatory surgical centers (ASCs), and specialty clinics. Hospitals remain the largest end-user segment due to their extensive capacity to perform complex vascular procedures and provide post-treatment care. However, ambulatory surgical centers are experiencing rapid growth, driven by the increasing demand for outpatient vascular treatments. These centers offer cost-effective and less invasive options, making them an attractive alternative to hospital settings. Specialty clinics, which focus on specific vascular treatments, also contribute significantly to the market, offering tailored care for patients with peripheral vascular conditions. The growing preference for minimally invasive procedures and outpatient care is shifting more treatments to ASCs and specialty clinics, expanding opportunities for peripheral vascular device manufacturers in these sectors. As healthcare delivery continues to evolve in Australia, these end-user segments will remain key drivers of market expansion.

Segments:

Based on Type:

  • Angioplasty Balloons
  • Angioplasty Stents
  • Catheters
  • Guidewires
  • Others

Based on End-user:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Based on the Geography:

  • New South Wales
  • Victoria
  • Queensland
  • Western Australia (WA)
  • South Australia

Regional Analysis

New South Wales (NSW) and Victoria

New South Wales (NSW) and Victoria lead the Australia Peripheral Vascular Devices market, accounting for the largest market share due to their well-established healthcare infrastructure and high population density. Together, these regions hold nearly 50% of the market share, driven by the increasing incidence of peripheral artery diseases (PAD) and the rising demand for advanced vascular treatments. NSW, home to Sydney, the country’s largest healthcare hub, has a robust network of hospitals and ambulatory surgical centers (ASCs), which are key end-users of peripheral vascular devices. Victoria, with Melbourne as its major city, follows closely in market share due to the high concentration of specialized vascular centers and advancements in medical technology. These regions are also at the forefront of innovation, incorporating cutting-edge technologies such as bioresorbable devices and minimally invasive treatments. The high adoption rate of advanced devices in these states is fueled by government policies supporting healthcare advancements and a growing elderly population that requires specialized care.

Queensland

Queensland holds a significant share of the Australian peripheral vascular devices market, accounting for approximately 20% of the total market. The state’s large geographical area and rapidly aging population have led to an increased demand for vascular treatments. Queensland’s healthcare sector has been expanding, with numerous hospitals and ASCs adopting advanced peripheral vascular devices to treat a growing number of PAD cases. Brisbane, the state’s capital, serves as a key center for medical innovation and research, further boosting the market for peripheral vascular devices. Moreover, Queensland’s government has prioritized improving healthcare access in regional areas, which is driving the expansion of peripheral vascular treatment options. The demand for minimally invasive procedures and specialized devices is particularly evident in Queensland’s rural and remote areas, where healthcare delivery models are evolving to meet the needs of the elderly population.

Western Australia (WA)

Western Australia (WA) holds a smaller share of the peripheral vascular devices market compared to NSW, Victoria, and Queensland, accounting for approximately 15%. Despite its lower share, WA is experiencing steady market growth due to the increasing awareness of vascular diseases and the adoption of advanced medical technologies. Perth, WA’s capital, is home to several leading hospitals and specialty clinics that utilize cutting-edge vascular devices. Additionally, the state’s large land area and remote communities are driving the need for better healthcare infrastructure in rural and regional areas. WA’s healthcare initiatives aim to expand access to peripheral vascular treatments, creating opportunities for market expansion. As the aging population in WA grows, the demand for peripheral vascular devices is expected to rise, particularly in rural areas where specialized care is needed to manage PAD and other vascular conditions.

South Australia

South Australia holds approximately 10% of the Australian peripheral vascular devices market, with Adelaide serving as the central hub for healthcare services in the state. While South Australia’s market share is smaller, it is poised for growth due to the increasing prevalence of peripheral vascular diseases and the state’s ongoing investment in healthcare infrastructure. The demand for peripheral vascular devices is growing, particularly in hospitals and specialty clinics that cater to an aging population. South Australia has been adopting more advanced medical technologies to improve treatment outcomes, including minimally invasive devices for peripheral artery interventions. The region’s focus on improving healthcare accessibility and enhancing diagnostic capabilities is expected to further boost the adoption of vascular devices. As the state continues to modernize its healthcare system, South Australia will likely experience a steady increase in the use of peripheral vascular devices in the coming years.

Key Player Analysis

  • Terumo Corporation
  • Medtronic plc
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Nipro Corporation
  • Cook Medical
  • Asahi Intecc Co., Ltd.
  • B. Braun Melsungen AG
  • MicroPort Scientific Corporation
  • Cardinal Health

Competitive Analysis

The competitive landscape of the Australia Peripheral Vascular Devices market is characterized by the presence of leading global players such as Terumo Corporation, Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Nipro Corporation, Cook Medical, Asahi Intecc Co., Ltd., B. Braun Melsungen AG, MicroPort Scientific Corporation, and Cardinal Health. Companies are focusing on expanding their product portfolios, particularly in minimally invasive devices, bioresorbable materials, and advanced imaging solutions. For instance, Terumo Corporation’s Ultimaster™ Tansei™ drug-eluting stent system has been shown to improve patient outcomes by reducing restenosis rates. Strategic partnerships and collaborations with healthcare providers are becoming common, helping to drive market penetration and increase accessibility to cutting-edge treatments. Additionally, strong investments in research and development (R&D) are allowing players to improve the efficacy and safety of vascular devices, meeting the growing demands of the aging population and increasing prevalence of peripheral artery diseases (PAD). Price competitiveness is another factor influencing the market, with companies offering differentiated products at various price points to cater to different healthcare settings, including hospitals, ambulatory surgical centers, and specialty clinics. As new players enter the market, the competition intensifies, driving manufacturers to focus on enhancing customer service, improving product performance, and ensuring regulatory compliance. The key differentiators for companies in the market include product quality, technological innovation, patient outcomes, and post-sales support. In this competitive environment, market leaders continue to strengthen their positions through aggressive expansion strategies, while emerging companies are trying to carve out niches with specialized solutions.

Recent Developments

  • In December 2024, Terumo Interventional Systems launched the R2P™ NaviCross® peripheral support catheter in the U.S. This catheter is designed for enhanced performance in radial-to-peripheral procedures, addressing the need for advanced tools in treating PAD and critical limb ischemia.
  • In October 2024, BD was highlighted as a key player in the peripheral vascular devices market forecast report. While specific recent product launches were not detailed, BD’s ongoing commitment to R&D and innovation positions it strongly within this competitive landscape.
  • In June 2023, Cook Medical announced new size options for its Advance Serenity PTA Balloon Catheter, used for treating peripheral artery disease (PAD).
  • In June 2023, Biotronik launched the Oscar multifunctional peripheral catheter, designed for dilation of stenotic segments in peripheral vessels. The device features user-adjustable components and aims to improve procedural efficiency in treating peripheral arterial disease.

Market Concentration & Characteristics

The market concentration of the Australia Peripheral Vascular Devices sector is moderately high, with a few dominant global players controlling a significant share of the market. This concentration is primarily driven by the presence of established multinational companies that offer a broad range of advanced vascular devices, from angioplasty balloons and stents to guidewires and catheters. These leading companies leverage their strong research and development (R&D) capabilities, vast distribution networks, and established relationships with healthcare providers to maintain their market dominance. Despite this concentration, there is still room for growth, especially for new players that specialize in niche products or innovative solutions. The characteristics of this market include a focus on technological innovation, particularly in minimally invasive procedures, bioresorbable devices, and improved catheter designs. Companies are investing heavily in R&D to enhance device performance, patient safety, and treatment outcomes. Additionally, the market is characterized by regulatory challenges, as products must meet stringent standards set by authorities like the Australian Therapeutic Goods Administration (TGA). Competitive differentiation is driven not only by product quality and technology but also by customer support, regulatory compliance, and the ability to adapt to changing healthcare demands. This creates a dynamic and evolving competitive environment, with players striving to address the increasing need for advanced, cost-effective vascular treatments.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Report Coverage

The research report offers an in-depth analysis based on Type, End-user and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

  1. The Australian Peripheral Vascular Devices market is expected to grow steadily due to the rising incidence of peripheral artery diseases (PAD).
  2. Technological advancements, such as bioresorbable devices and minimally invasive treatment options, will drive the adoption of new vascular devices.
  3. The aging population in Australia will continue to fuel demand for peripheral vascular treatments and devices.
  4. Market players will invest heavily in research and development to introduce more efficient, safer, and cost-effective devices.
  5. The increasing preference for outpatient treatments in ambulatory surgical centers will expand market opportunities.
  6. The availability of innovative imaging tools for real-time diagnostics will enhance the precision of vascular procedures.
  7. Regulatory bodies will enforce stricter guidelines, promoting higher product safety standards and ensuring better patient outcomes.
  8. Emerging companies specializing in specialized devices will carve out niche markets, contributing to overall market expansion.
  9. Collaborations between device manufacturers and healthcare providers will increase access to advanced peripheral vascular treatments.
  10. The overall market growth will be supported by government initiatives aimed at improving healthcare infrastructure and accessibility.

CHAPTER NO. 1 : INTRODUCTION 19
1.1.1. Report Description 19
Purpose of the Report 19
USP & Key Offerings 19
1.1.2. Key Benefits for Stakeholders 19
1.1.3. Target Audience 20
1.1.4. Report Scope 20
CHAPTER NO. 2 : EXECUTIVE SUMMARY 21
2.1. Peripheral Vascular Devices Market Snapshot 21
2.1.1. Australia Peripheral Vascular Devices Market, 2018 – 2032 (USD Million) 22
CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 23
3.1. Russia-Ukraine and Israel-Palestine War Impacts 23
CHAPTER NO. 4 : PERIPHERAL VASCULAR DEVICES MARKET – INDUSTRY ANALYSIS 24
4.1. Introduction 24
4.2. Market Drivers 25
4.2.1. Increasing prevalence of peripheral artery disease and other vascular conditions 25
4.2.2. Technological advancements in minimally invasive procedures 26
4.3. Market Restraints 27
4.3.1. High cost of peripheral vascular devices and associated procedures 27
4.4. Market Opportunities 28
4.4.1. Growing demand for peripheral vascular devices in emerging economies 28
4.5. Porter’s Five Forces Analysis 29
4.6. Buying Criteria 30
CHAPTER NO. 5 : IMPORT EXPORT ANALYSIS 31
5.1. Import Analysis by Australia 31
5.1.1. Australia Peripheral Vascular Devices Market Import Volume/Revenue, By Australia, 2018 – 2023 31
5.2. Export Analysis by Australia 32
5.2.1. Australia Peripheral Vascular Devices Market Export Volume/Revenue, By Australia, 2018 – 2023 32
CHAPTER NO. 6 : DEMAND SUPPLY ANALYSIS 33
6.1. Demand Analysis by Australia 33
6.1.1. Australia Peripheral Vascular Devices Market Demand Volume/Revenue, By Australia, 2018 – 2023 33
6.2. Supply Analysis by Australia 34
6.2.1. Australia Peripheral Vascular Devices Market Supply Volume/Revenue, By Australia, 2018 – 2023 34
CHAPTER NO. 7 : PRODUCTION ANALYSIS 35
7.1. Production Analysis by Australia 35
7.1.1. Australia Peripheral Vascular Devices Market Production Volume/Revenue, By Australia, 2018 – 2023 35
CHAPTER NO. 8 : PRICE ANALYSIS 36
8.1. Price Analysis by Type 36
8.1.1. Australia Peripheral Vascular Devices Market Price, By Type, 2018 – 2023 36
8.1.2. Australia Type Market Price, By Type, 2018 – 2023 36
CHAPTER NO. 9 : RAW MATERIALS ANALYSIS 37
9.1. Key Raw Materials and Suppliers 37
9.2. Key Raw Materials Price Trend 37
CHAPTER NO. 10 : MANUFACTURING COST ANALYSIS 38
10.1. Manufacturing Cost Analysis 38
10.2. Manufacturing Process 38
CHAPTER NO. 11 : ANALYSIS COMPETITIVE LANDSCAPE 39
11.1. Company Market Share Analysis – 2023 39
11.2. Value Chain Analysis 39
11.2.1. Australia Peripheral Vascular Devices Market: Company Market Share, by Volume, 2023 40
11.2.2. Australia Peripheral Vascular Devices Market: Company Market Share, by Revenue, 2023 41
11.2.3. Australia Peripheral Vascular Devices Market: Top 6 Company Market Share, by Revenue, 2023 41
11.2.4. Australia Peripheral Vascular Devices Market: Top 3 Company Market Share, by Revenue, 2023 42
11.3. Australia Peripheral Vascular Devices Market Company Volume Market Share, 2023 43
11.4. Australia Peripheral Vascular Devices Market Company Revenue Market Share, 2023 44
11.5. Company Assessment Metrics, 2023 44
11.5.1. Stars 44
11.5.2. Emerging Leaders 44
11.5.3. Pervasive Players 44
11.5.4. Participants 44
11.6. Start-ups /SMEs Assessment Metrics, 2023 44
11.6.1. Progressive Companies 44
11.6.2. Responsive Companies 45
11.6.3. Dynamic Companies 45
11.6.4. Starting Blocks 45
11.7. Strategic Developments 46
11.7.1. Acquisitions & Mergers 46
New Product Launch 46
Australia Expansion 46
11.8. Key Players Product Matrix 47
CHAPTER NO. 12 : PESTEL & ADJACENT MARKET ANALYSIS 48
12.1. PESTEL 48
12.1.1. Political Factors 48
12.1.2. Economic Factors 48
12.1.3. Social Factors 48
12.1.4. Technological Factors 48
12.1.5. Environmental Factors 48
12.1.6. Legal Factors 48
12.2. Adjacent Market Analysis 48
CHAPTER NO. 13 : PERIPHERAL VASCULAR DEVICES MARKET – BY TYPE SEGMENT ANALYSIS 49
13.1. Peripheral Vascular Devices Market Overview, by Type Segment 49
13.1.1. Peripheral Vascular Devices Market Revenue Share, By Type, 2023 & 2032 50
13.1.2. Peripheral Vascular Devices Market Attractiveness Analysis, By Type 51
13.1.3. Incremental Revenue Growth Opportunity, by Type, 2024 – 2032 51
13.1.4. Peripheral Vascular Devices Market Revenue, By Type, 2018, 2023, 2027 & 2032 52
13.2. Angioplasty Balloons 53
13.3. Angioplasty Stents 54
13.4. Catheters 55
13.5. Guidewires 56
13.6. Others 57
CHAPTER NO. 14 : PERIPHERAL VASCULAR DEVICES MARKET – BY END-USER SEGMENT ANALYSIS 58
14.1. Peripheral Vascular Devices Market Overview, by End-user Segment 58
14.1.1. Peripheral Vascular Devices Market Revenue Share, By End-user, 2023 & 2032 59
14.1.2. Peripheral Vascular Devices Market Attractiveness Analysis, By End-user 60
14.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 60
14.1.4. Peripheral Vascular Devices Market Revenue, By End-user, 2018, 2023, 2027 & 2032 61
14.2. Hospitals 62
14.3. Ambulatory Surgical Centers 63
14.4. Specialty Clinics 64
CHAPTER NO. 15 : PERIPHERAL VASCULAR DEVICES MARKET – AUSTRALIA ANALYSIS 65
15.1. Type 65
15.1.1. Australia Peripheral Vascular Devices Market Revenue, By Type, 2018 – 2023 (USD Million) 65
15.2. Australia Peripheral Vascular Devices Market Revenue, By Type, 2024 – 2032 (USD Million) 65
15.3. End-user 66
15.3.1. Australia Peripheral Vascular Devices Market Revenue, By End-user, 2018 – 2023 (USD Million) 66
15.3.2. Australia Peripheral Vascular Devices Market Revenue, By End-user, 2024 – 2032 (USD Million) 66
CHAPTER NO. 16 : COMPANY PROFILES 67
16.1. Terumo Corporation 67
16.1.1. Company Overview 67
16.1.2. Product Portfolio 67
16.1.3. Swot Analysis 67
16.1.4. Business Strategy 68
16.1.5. Financial Overview 68
16.2. Medtronic plc 69
16.3. Boston Scientific Corporation 69
16.4. Abbott Laboratories 69
16.5. Nipro Corporation 69
16.6. Cook Medical 69
16.7. Asahi Intecc Co., Ltd. 69
16.8. B. Braun Melsungen AG 69
16.9. MicroPort Scientific Corporation 69
16.10. Cardinal Health 69

List of Figures
FIG NO. 1. Australia Peripheral Vascular Devices Market Revenue, 2018 – 2032 (USD Million) 22
FIG NO. 2. Porter’s Five Forces Analysis for Australia Peripheral Vascular Devices Market 29
FIG NO. 3. Australia Peripheral Vascular Devices Market Import Volume/Revenue, By Australia, 2018 – 2023 31
FIG NO. 4. Australia Peripheral Vascular Devices Market Export Volume/Revenue, By Australia, 2018 – 2023 32
FIG NO. 5. Australia Peripheral Vascular Devices Market Demand Volume/Revenue, By Australia, 2018 – 2023 33
FIG NO. 6. Australia Peripheral Vascular Devices Market Supply Volume/Revenue, By Australia, 2018 – 2023 34
FIG NO. 7. Australia Peripheral Vascular Devices Market Production Volume/Revenue, By Australia, 2018 – 2023 35
FIG NO. 8. Australia Peripheral Vascular Devices Market Price, By Type, 2018 – 2023 36
FIG NO. 9. Raw Materials Price Trend Analysis, 2018 – 2023 37
FIG NO. 10. Manufacturing Cost Analysis 38
FIG NO. 11. Manufacturing Process 38
FIG NO. 12. Value Chain Analysis for Australia Peripheral Vascular Devices Market 39
FIG NO. 13. Company Share Analysis, 2023 40
FIG NO. 14. Company Share Analysis, 2023 41
FIG NO. 15. Company Share Analysis, 2023 41
FIG NO. 16. Company Share Analysis, 2023 42
FIG NO. 17. Peripheral Vascular Devices Market – Company Volume Market Share, 2023 43
FIG NO. 18. Peripheral Vascular Devices Market – Company Revenue Market Share, 2023 44
FIG NO. 19. Peripheral Vascular Devices Market Revenue Share, By Type, 2023 & 2032 50
FIG NO. 20. Market Attractiveness Analysis, By Type 51
FIG NO. 21. Incremental Revenue Growth Opportunity by Type, 2024 – 2032 51
FIG NO. 22. Peripheral Vascular Devices Market Revenue, By Type, 2018, 2023, 2027 & 2032 52
FIG NO. 23. Australia Peripheral Vascular Devices Market for Angioplasty Balloons, Revenue (USD Million) 2018 – 2032 53
FIG NO. 24. Australia Peripheral Vascular Devices Market for Angioplasty Stents, Revenue (USD Million) 2018 – 2032 54
FIG NO. 25. Australia Peripheral Vascular Devices Market for Catheters, Revenue (USD Million) 2018 – 2032 55
FIG NO. 26. Australia Peripheral Vascular Devices Market for Guidewires, Revenue (USD Million) 2018 – 2032 56
FIG NO. 27. Australia Peripheral Vascular Devices Market for Others, Revenue (USD Million) 2018 – 2032 57
FIG NO. 28. Peripheral Vascular Devices Market Revenue Share, By End-user, 2023 & 2032 59
FIG NO. 29. Market Attractiveness Analysis, By End-user 60
FIG NO. 30. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 60
FIG NO. 31. Peripheral Vascular Devices Market Revenue, By End-user, 2018, 2023, 2027 & 2032 61
FIG NO. 32. Australia Peripheral Vascular Devices Market for Hospitals, Revenue (USD Million) 2018 – 2032 62
FIG NO. 33. Australia Peripheral Vascular Devices Market for Ambulatory Surgical Centers, Revenue (USD Million) 2018 – 2032 63
FIG NO. 34. Australia Peripheral Vascular Devices Market for Specialty Clinics, Revenue (USD Million) 2018 – 2032 64


List of Tables
TABLE NO. 1. : Australia Peripheral Vascular Devices Market: Snapshot 21
TABLE NO. 2. : Drivers for the Peripheral Vascular Devices Market: Impact Analysis 25
TABLE NO. 3. : Restraints for the Peripheral Vascular Devices Market: Impact Analysis 27
TABLE NO. 4. : Australia Peripheral Vascular Devices Market Revenue, By Type, 2018 – 2023 36
TABLE NO. 5. : Key Raw Materials & Suppliers 37
TABLE NO. 6. : Australia Peripheral Vascular Devices Market Revenue, By Type, 2018 – 2023 (USD Million) 65
TABLE NO. 7. : Australia Peripheral Vascular Devices Market Revenue, By Type, 2024 – 2032 (USD Million) 65
TABLE NO. 8. : Australia Peripheral Vascular Devices Market Revenue, By End-user, 2018 – 2023 (USD Million) 66
TABLE NO. 9. : Australia Peripheral Vascular Devices Market Revenue, By End-user, 2024 – 2032 (USD Million) 66

Frequently Asked Questions:

What is the current size of the Australia Peripheral Vascular Devices market?

The Australia Peripheral Vascular Devices market was valued at USD 75.14 million in 2023 and is projected to grow to USD 128.02 million by 2032, reflecting a compound annual growth rate (CAGR) of 6.89%.

What factors are driving the growth of the Australia Peripheral Vascular Devices market?

The market growth is primarily driven by the increasing prevalence of peripheral artery diseases (PAD) and the growing aging population in Australia. Technological advancements, such as minimally invasive procedures and bioresorbable vascular devices, along with improved healthcare infrastructure and government initiatives, also contribute significantly to market expansion.

What are the key segments within the Australia Peripheral Vascular Devices market?

The market is segmented by type into angioplasty balloons, angioplasty stents, catheters, guidewires, and others. By end-users, the segments include hospitals, ambulatory surgical centers (ASCs), and specialty clinics. Geographically, key regions include New South Wales, Victoria, Queensland, Western Australia, and South Australia.

What are some challenges faced by the Australia Peripheral Vascular Devices market?

High treatment costs and reimbursement issues limit accessibility for certain patient populations. Stringent regulatory requirements enforced by the Australian Therapeutic Goods Administration (TGA) also pose challenges, delaying product approvals and increasing development costs. Additionally, intense competition among established global players makes it difficult for smaller companies to gain market share.

Who are the major players in the Australia Peripheral Vascular Devices market?

Key players in the market include Terumo Corporation, Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Nipro Corporation, Cook Medical, Asahi Intecc Co., Ltd., B. Braun Melsungen AG, MicroPort Scientific Corporation, and Cardinal Health. These companies focus on innovation, minimally invasive technologies, and strategic partnerships to maintain their competitive edge.

Australia AC-DC Power Supply in Data Center Market

Published:
Report ID: 74869

Australia Data Center Filters Market

Published:
Report ID: 74721

Australia Occupational Health Market

Published:
Report ID: 61938

Australia Grid Modernization Market

Published:
Report ID: 73498

Australia Data Center Security Market

Published:
Report ID: 73460

Australia Data Center Processor Market

Published:
Report ID: 73239

Australia Building Decoration Market

Published:
Report ID: 72997

Australia Industry Vertical Modernization Services Market

Published:
Report ID: 72975

Australia Police Modernization Market

Published:
Report ID: 72583

Internal Radiation Therapy Market

Published:
Report ID: 75411

Image Guided Radiotherapy Market

Published:
Report ID: 75382

Flat Panel X-Ray Detectors Market

Published:
Report ID: 74896

Hemostasis Testing Systems Market

Published:
Report ID: 74856

Cardiac Ultrasound Systems Market

Published:
Report ID: 74702

Aesthetic Medical Devices Market

Published:
Report ID: 74587

Italy Diabetes Care Devices Market

Published:
Report ID: 64898

Transplant Monitoring Kits Market

Published:
Report ID: 74464

Malignant Pleural Effusion Market

Published:
Report ID: 74366

Angiography Imaging Systems Market

Published:
Report ID: 74155

Electrosurgery Accessories Market

Published:
Report ID: 74130

Digital Psychotherapeutics Market

Published:
Report ID: 73007

Purchase Options

The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing.
$2699

To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis and multi-location access, making it an excellent choice for organizations with distributed workforce.
$3699

The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc.’s research team. It is highly recommended for organizations seeking to execute short, customized research projects related to the scope of the purchased report.
$5699

Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN